Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Agios Pharmaceuticals (AGIO)

Agios Pharmaceuticals (AGIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Agios Pharmaceuticals Reports Tomorrow With Analysts Already Lowering Next Year's Numbers Barchart - Wed Jul 29, 4:01PM CDT

Barchart Research What to Expect from AGIO Earnings AGIO Generated July 29, 2026 Current Price $35.01 EPS Estimate $$-1.86 Consensus Rating Moderate Buy Average Move 4.00% Agios Pharmaceuticals Reports...

AGIO : 35.01 (-2.72%)
NASDAQ sign at times square at night by Lucky-photographer via iStock
Stock Indexes Settle Higher as Chipmakers Soar Barchart - Tue Jul 21, 3:38PM CDT

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.89%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.74%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.93%. September E-mini...

TER : 319.41 (-0.39%)
MSTR : 93.33 (-2.94%)
SNDK : 1,015.89 (-7.32%)
GLXY : 18.26 (-12.80%)
TRI : 106.34 (+2.95%)
COIN : 160.09 (-4.65%)
STX : 764.43 (+2.29%)
WDC : 462.04 (-0.32%)
AMD : 429.56 (-5.51%)
^BTCUSD : 63,895.75 (+0.75%)
SPY : 729.46 (-1.54%)
ADSK : 245.25 (+3.32%)
Computer memory by Zoomik via Shutterstock
Strength in Chipmakers Boosts Stocks Barchart - Tue Jul 21, 10:11AM CDT

The S&P 500 Index ($SPX ) (SPY ) today is up +0.64%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.58%. September E-mini S&P futures...

TER : 319.41 (-0.39%)
MSTR : 93.33 (-2.94%)
AMAT : 436.45 (-8.40%)
SNDK : 1,015.89 (-7.32%)
GLXY : 18.26 (-12.80%)
DDOG : 264.20 (+5.31%)
TRI : 106.34 (+2.95%)
$IUXX : 27,192.31 (-2.06%)
COIN : 160.09 (-4.65%)
ASML : 1,550.69 (-2.04%)
DHR : 196.49 (-1.29%)
ZNU26 : 108-075 (-0.50%)
Wall street sign in New York City with American flags and New York Stock Exchange in background by kasto80 via iStock
Stocks Gain as Chipmakers Rebound Barchart - Tue Jul 21, 9:06AM CDT

The S&P 500 Index ($SPX ) (SPY ) today is up +0.38%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.17%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.26%. September E-mini S&P futures...

TER : 319.41 (-0.39%)
MSTR : 93.33 (-2.94%)
AMAT : 436.45 (-8.40%)
SNDK : 1,015.89 (-7.32%)
INTU : 333.13 (+6.43%)
GLXY : 18.26 (-12.80%)
DDOG : 264.20 (+5.31%)
$IUXX : 27,192.31 (-2.06%)
COIN : 160.09 (-4.65%)
ASML : 1,550.69 (-2.04%)
DHR : 196.49 (-1.29%)
ZNU26 : 108-075 (-0.50%)
Agios Provides Update on Phase 2 Trial of Tebapivat in Sickle Cell Disease GlobeNewswire - Tue Jul 21, 6:00AM CDT

Hemoglobin response rates for tebapivat, a PK activator, were consistent with the class of medicine, but Phase 2 results did not establish a differentiated profile to support continued development in sickle...

AGIO : 35.01 (-2.72%)
U.S. FDA Grants Priority Review to Agios’ sNDA for Mitapivat in Sickle Cell Disease GlobeNewswire - Tue Jul 7, 6:00AM CDT

FDA’s PDUFA goal date is November 1, 2026 If approved, mitapivat is positioned to become the first oral PK activator for patients with sickle cell disease CAMBRIDGE, Mass., July 07, 2026 (GLOBE...

AGIO : 35.01 (-2.72%)
Agios to Host Second Quarter 2026 Financial Results Conference Call and Webcast on July 30 at 8:00 a.m. ET GlobeNewswire - Mon Jun 29, 6:00AM CDT

CAMBRIDGE, Mass., June 29, 2026 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with...

AGIO : 35.01 (-2.72%)
Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease GlobeNewswire - Sat Jun 13, 8:00AM CDT

Mitapivat demonstrated statistically significant improvement in hemoglobin response compared with placebo, with rapid onset and durable effects New analyses showed patients in mitapivat arm had clinically...

AGIO : 35.01 (-2.72%)
Agios Enters Exclusive Global License Agreement with Oscotec to Develop and Commercialize Next-Generation SYK Inhibitor Cevidoplenib GlobeNewswire - Mon Jun 1, 4:00AM CDT

Agios obtains exclusive global rights to novel, late-stage, next-generation, oral SYK inhibitor Agreement diversifies Agios’ rare hematology portfolio with expansion into immune thrombocytopenia,...

AGIO : 35.01 (-2.72%)
Agios Provides Update on Phase 2b Trial of Tebapivat in Lower-Risk Myelodysplastic Syndromes GlobeNewswire - Fri May 29, 6:00AM CDT

Results did not meet predefined threshold to support further development in LR-MDS Tebapivat was well tolerated, with no new safety signals observed CAMBRIDGE, Mass., May 29, 2026 (GLOBE NEWSWIRE)...

AGIO : 35.01 (-2.72%)

Barchart Exclusives

This Dividend Stock Is Up 22% in a Month Despite Mixed Q2 Earnings. Don’t Sell Just Yet. Barchart - Wed Jul 29, 6:30PM CDT
Domino’s Pizza stock has rebounded sharply from its 2026 lows. While its valuation multiples have expanded and DPZ does not look as tempting now, dividend investors can stay put in the stock. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.